[ESPR] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
07-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 52.32%
YoY- 28.43%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 51,632 33,969 18,980 14,409 3,833 981 0 -
PBT -29,524 -41,250 -55,117 -69,386 -85,437 -68,377 -49,911 -8.37%
Tax 0 -26 13,494 13,667 4,970 5,383 0 -
NP -29,524 -41,250 -68,611 -69,386 -85,437 -68,377 -49,911 -8.37%
Tax Rate - - - - - - - -
Total Cost 81,156 75,219 87,591 83,795 89,270 69,358 49,911 8.43%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -57.18 -121.43 -361.49 -481.55 -2,228.99 -6,970.13 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.15 -0.37 -1.01 -2.62 -3.07 -2.52 -1.86 -34.24%
EPS Diluted -0.15 -0.37 -1.01 -2.62 -3.07 -2.52 -1.86 -34.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.